Skip to search formSkip to main contentSkip to account menu

rolofylline

Known as: 1,3-dipropyl-8-(3-noradamantyl)xanthine, 1,3-dipropyl-8-(tricyclo(3.3.1.0(sup 3,7))non-3-yl)-3,7-dihydro-1h-purine-2,6-dione, 1,3-DNAX 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

DiureticsXanthines

Narrower (2)

KW-3902MK 7418

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The disconnect between phase II and phase III trials of drugs for heart failure
Hospitalization for heart failure (HF) is a clinical entity associated with high postdischarge morbidity and mortality, yet few… 
2013
2013
Computational Profiling of Bioactive Compounds Using a Target-Dependent Composite Workflow
Computational target fishing is a chemoinformatic method aimed at determining main and secondary targets of bioactive compounds… 
2010
2010
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function
The direct effects of adenosine A1 receptor antagonists on haemodynamic parameters in patients with acute heart failure (HF… 
2002
2002
Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction
We investigated the contributions of adenosine A1 receptors to angiotensin II- and norepinephrine-induced renal vasoconstriction… 
2000
2000
[Effect of KW-3902, a selective adenosine A1-receptor antagonist, on accumulation of gentamicin in the proximal renal tubules in rats].
  • K. Yao
  • Yakugaku zasshi : Journal of the Pharmaceutical…
  • 2000
  • Corpus ID: 36010836
Adenosine A1-receptor antagonists have been previously shown to possess protective effects in several nephrotoxic models of acute… 
2000
2000
Effect of the selective adenosine A1-receptor antagonist KW-3902 on tubuloglomerular feedback in radiocontrast-media-induced nephropathy in rats with chronic nitric oxide deficiency.
To study the possible mechanism of renoprotective effects of adenosine A1-receptor antagonist against radiocontrast media (RCM… 
1996
1996
Effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urinary excretions of various electrolytes in rats.
We examined the effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), an adenosine A1-receptor antagonist, on urine… 
1994
1994
Effects of KW-3902, a novel adenosine A1-receptor antagonist, on cephaloridine-induced acute renal failure in rats.
We investigated the possible renal protective effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a selective and… 
1993
1993
Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, in conscious dogs.
The diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine), a novel adenosine A1 receptor antagonist, were… 
1993
1993
Effects of adenosine A1-agonist and -antagonist on urinary volume and Na excretion in IAP-treated and non-treated rats.
Effects of an adenosine A1-receptor agonist and antagonist were determined in pertussis toxin (IAP)-treated and non-treated rats… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)